Lundbeck
HLUN-B.CO
#2243
Rank
C$11.83 B
Marketcap
C$11.93
Share price
0.54%
Change (1 day)
18.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): C$0.48

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$1.07. In 2022 the company made an earnings per share (EPS) of C$0.38 a decrease over its 2021 EPS that were of C$0.85.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$0.4826.14%
2022C$0.38-55.47%
2021C$0.85-51.83%
2020C$1.77-28.01%
2019C$2.46-44.08%
2018C$4.3951.94%
2017C$2.89126.64%
2016C$1.28-120.84%
2015C-$6.125622.18%
2014C-$0.11-110.03%
2013C$1.07-28.08%
2012C$1.48-52.1%
2011C$3.09-1.31%
2010C$3.1415.61%
2009C$2.71